Live Breaking News & Updates on Bharat biotech pvt ltd

Stay informed with the latest breaking news from Bharat biotech pvt ltd on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Bharat biotech pvt ltd and stay connected to the pulse of your community

Bharat Biotech dispatches first shipments of iNCOVACC across India

The Bharat Biotech on Monday dispatched the first shipments of World first intranasal Covid19 vaccine-- iNCOVACC to various locations across India.

India , Bharat , Krishna-ella , Mansukh-mandaviya , Jitendra-singh , Union-health , Bharat-biotech-pvt-ltd , Health-center , Bharat-biotech-international-limited , Ella-foundation , Uw-madison-global-health-institute , Shalini-bhardwajnew-delhi

We dispatched nasal vaccines to hospitals two days ago: Bharat Biotech Executive Chairman Dr Krishna Ella

The Bharat Biotech Pvt Ltd has started dispatching the world's first Intranasal heterologous booster dose to the hospitals, the executive chairman of Bharat Biotech, Dr Krishna Ella, informed on Sunday.

India , Bharat , Krishna-ella , Mansukh-mandaviya , Union-health , Bharat-biotech-pvt-ltd , Health-center , Technology-jitendra-singh , Bharat-biotech-international-limited , Ella-foundation , Uw-madison-global-health-institute , Bharat-biotech

India News | We Dispatched Nasal Vaccines to Hospitals Two Days Ago: Bharat Biotech Executive Chairman Dr Krishna Ella

Get latest articles and stories on India at LatestLY. Speaking to ANI, Dr Krishna Ella said, "We just dispatched nasal vaccines two days ago to the hospitals." India News | We Dispatched Nasal Vaccines to Hospitals Two Days Ago: Bharat Biotech Executive Chairman Dr Krishna Ella.

Uttar-pradesh , India , New-delhi , Delhi , Bharat , Krishna-ella , Shalini-bharadwaj , Mansukh-mandaviya , Union-health , Bharat-biotech-pvt-ltd , Health-center , Technology-jitendra-singh

Supply Enough Doses To Inoculate Madhya Pradesh's Entire Adult Population: Court To Centre

Supply Enough Doses To Inoculate Madhya Pradesh's Entire Adult Population: Court To Centre
ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.

Madhya-pradesh , India , Bharat , Justice-satyendra-kumar-singh , Justice-mohammed-rafiq , Chhavi-bhardwaj , Bharat-biotech-pvt-ltd , Court-to-centre-senior , National-health-mission-madhya-pradesh , Serum-institute-of-india , Madhya-pradesh-high-court , Entire-adult-population

India starts COVID-19 vaccination drive; Modi calls doubts over vaccine 'propaganda'

India starts COVID-19 vaccination drive; Modi calls doubts over vaccine 'propaganda'
downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.

Bhopal , Madhya-pradesh , India , United-states , Bharat , Narendra-modi , Randeep-guleria , Bharat-biotech-pvt-ltd , University-of-oxford , Indian-council-of-medical-research , Reuters , Pfizer

Nifty today: SGX Nifty up 10 points; here's what changed for market while you were sleeping

Synopsis
Asian shares are set to end a tumultuous 2020 by hovering near record highs on Thursday, buoyed by hopes that COVID-19 vaccine rollouts will help the world beat the pandemic.
Getty Images
India 10-year bond yield fell 0.73 per cent to 5.93 after trading in 5.89-5.93 range.
Domestic benchmark indices looked set for a cautious start on Thursday amid the expiry of December series futures & options contracts. Here's breaking down the pre-market actions:
STATE OF THE MARKETS
Nifty futures on the Singapore Exchange traded 13 points, or 0.09 per cent, higher at 14,063, in signs that Dalal Street was headed for a flat to positive start on Thursday.

Germany , Australia , Doji , Kanagawa , Japan , India , United-kingdom , Singapore , China , Britain , Australian , Bharat

CDSCO Officials Will Meet On Jan 1 To Discuss Emergency Use Authorization Of COVID Vaccines

CDSCO Officials Will Meet On Jan 1 To Discuss Emergency Use Authorization Of COVID Vaccines
Dec 31, 2020, 16:24 IST
The Subject Expert Committee (SEC) in Central Drugs Standard Control Organisation (CDSCO) met on Wednesday to consider the Emergency Use Authorisation (EUA) request of Pfizer, Serum Institute of India (SII) and Bharat Biotech Pvt Limited.
According to the statement by the SEC, the Emergency Use was not authorized on Wednesday. They need more data and further time to discuss. The SEC will meet again on January 1. After reviewing further details, they will take a decision about Emergency use of COVID-19 vaccine in India.
Pfizer had asked for more time. “Further time was requested on behalf of Pfizer. The additional data and information presented by SII and Bharat Biotech Pvt Ltd. was perused and analysed by SEC.

India , United-kingdom , Bharat , Bharat-biotech-pvt-ltd , Central-drugs-standard-control-organisation , Bharat-biotech-pvt , Pfizer , Astrazeneca , Serum-institute , Serum-institute-of-india , Expert-committee

COVID-19: No Emergency Use Approval granted to Oxford-AstraZeneca vaccine in India

Highlights
SEC in CDSCO on Wednesday did not grant EUA to COVID-19 vaccine developed by Oxford-AstraZeneca for use in India.
The SEC also refused to consider the EUA request of Pfizer and Bharat Biotech Pvt Limited.
The SEC is scheduled to meet again on January 1 to hold discussions over this matter.
In a significant development, the Subject Expert Committee (SEC) in Central Drugs Standard Control Organisation (CDSCO) on Wednesday (December 30) did not grant EUA to COVID-19 vaccine developed by Oxford-AstraZeneca for use in India. The SEC also refused to consider the Emergency Use Authorisation (EUA) request of Pfizer and Bharat Biotech Pvt Limited saying that vaccines developed by all these companies will not be given authorisation “yet” as more data is needed.

India , United-kingdom , Bharat , Bharat-biotech-pvt-ltd , Oxford-university-astrazeneca , Health-ministry , Central-drugs-standard-control-organisation , Bharat-biotech-pvt , Regulatory-agency , Pfizer , Astrazeneca

Covid-19 vaccine emergency use authorisation soon? SEC meets to consider Pfizer, Serum, Bharat Biotech requests

millennials
Covid-19 vaccine emergency use authorisation soon? SEC meets to consider Pfizer, Serum, Bharat Biotech requests
© Provided by The Financial Express
Coronavirus Covid 19 vaccine emergency use authorisation: (Reuters/Representational Photo)
Covid-19 vaccine emergency use authorisation: The Ministry of Health and Family Welfare informed on Wednesday that the Subject Expert Committee (SEC) in Central Drugs Standard Control Organisation (CDSCO) held a meeting to consider the Emergency Use Authorisation (EUA) request of Pfizer, Serum Institute of India (SII) and Bharat Biotech Pvt Ltd.
The health ministry also informed that more time was requested on behalf of Pfizer.
Also, the additional data and information presented by the Serum Institute of India and Bharat Biotech Pvt Ltd was perused and analysed by SEC.

India , Hyderabad , Andhra-pradesh , United-kingdom , Singapore , Pune , Maharashtra , Bharat , Bharat-biotech-pvt-ltd , University-of-oxford , Ministry-of-health

Indian regulator seeks more time as UK authorises Oxford COVID-19 jab; six things about cheap, easy to store vaccine

Indian regulator seeks more time as UK authorises Oxford COVID-19 jab; six things about cheap, easy to store vaccine
In India, a decision on emergency usage of the vaccine, which is being manufactured by Pune-based Serum Institute of India, is likely to come next year with the Subject Expert Committee (SEC) on COVID-19 seeking more time today
FP Staff
December 30, 2020 22:48:25 IST
Representational image.
British regulator granted emergency usage authorisation to the easy to store and cheap AstraZeneca/Oxford vaccine on Wednesday.
Though the Indian authorities on Wednesday sought more time to decide on the emergency authorisation of the vaccine, which is manufactured in India as 'Covishield' by Pune-based Serum Institute of India in a tie-up with AstraZeneca, the UK's authorisation has given a shot in the arm to the global fight against coronavirus

India , United-kingdom , Britain , British , Bharat , Astrazeneca-oxford , Pascal-soriot , Boris-johnson , Bharat-biotech-pvt-ltd , Health-ministry , Central-drugs-standard-control-organisation , Regulatory-agency